RVPH - Reviva Pharmaceuticals Holdings Inc.

RVPH - Reviva Pharmaceuticals Holdings Inc.

https://www.revivapharma.com

Recent News

Powered by Alpha Vantage

Reviva to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference

GlobeNewswire • 3 months, 1 week ago • score: -0.18

CUPERTINO, Calif., June 05, 2025 ( GLOBE NEWSWIRE ) -- Reviva Pharmaceuticals Holdings, Inc. ( NASDAQ: RVPH ) ( "Reviva" or the "Company" ) , a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system ( CNS ) , ...

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

None

52W High

$2.99

52W Low

$0.30

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

-0.05

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-6.00

EV/Revenue (<3 favorable)

N/A

P/S (TTM) (<3 favorable)

N/A

P/B (<3 favorable)

47.17

Ownership

Retail‑heavy

Source: Overview

Insiders (1–5% typical)

7.27%

Institutions (25–75% balanced)

21.07%

Shares Outstanding

68,004,000

Float

60,916,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

0

Gross Profit (TTM)

0

EPS (TTM)

-0.64

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

N/A

ROE (TTM) (>15% strong)

-9.16%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

N/A

Momentum

Value

N/A

Previous

N/A

Trend

—

Signal Cross

No cross

As of

—